This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jan;4(1):16-7.

doi: 10.1038/ncponc0683.

Should young patients with neuroblastoma receive high-dose platinum compounds?

Penelope R Brock¹

Affiliations

PMID: 17183352
DOI: 10.1038/ncponc0683

Comment

Should young patients with neuroblastoma receive high-dose platinum compounds?

Penelope R Brock. Nat Clin Pract Oncol. 2007 Jan.

. 2007 Jan;4(1):16-7.

doi: 10.1038/ncponc0683.

Author

Penelope R Brock¹

Affiliation

¹ Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London WC1N 3JH, UK. brockp@gosh.nhs.uk

PMID: 17183352
DOI: 10.1038/ncponc0683

No abstract available

PubMed Disclaimer

Comment on

Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.
Kushner BH, Budnick A, Kramer K, Modak S, Cheung NK. Kushner BH, et al. Cancer. 2006 Jul 15;107(2):417-22. doi: 10.1002/cncr.22004. Cancer. 2006. PMID: 16779793 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.